foxo4-dri senolytic peptide mechanism The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI: Human Trial Status, Cancer
FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOX04 DRI (10mg) Nordsci FOXO4 DRI Peptide Senolytic & Longevity Research PeptWorld Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry
Pay in 4 interest-free payments of $5.94 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



